Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6.66M Buy
146,300
+44,700
+44% +$2.17M ﹤0.01% 1767
2014
Q2
$5.24M Buy
101,600
+64,200
+172% +$3.16M ﹤0.01% 1917
2014
Q1
$1.83M Sell
37,400
-32,400
-46% -$1.57M ﹤0.01% 2867
2013
Q4
$3.03M Sell
69,800
-12,300
-15% -$506K ﹤0.01% 2384
2013
Q3
$3.13M Buy
82,100
+23,500
+40% +$827K ﹤0.01% 2135
2013
Q2
$1.82M Buy
+58,600
New +$1.75M ﹤0.01% 2643

Other funds holding VTRS

UBS's VTRS Position: Q3 2014 in Review

UBS increased its Viatris (VTRS) stake by 41% in Q3 2014, buying an estimated $15M and bringing the position to 1,058,091 shares worth $48.1M. The position accounts for 0.04% of the portfolio, ranked #526.

UBS first reported a position in VTRS in Q2 2013 and has held it in 6 quarters since. 629 funds tracked by Wall St. Rank hold VTRS as of Q3 2014.

  • UBS held 1,058,091 shares of Viatris worth $48.1M as of Q3 2014.
  • UBS bought 307,893 Viatris shares in Q3 2014, an estimated $15M.
  • Viatris made up 0.04% of UBS's portfolio in Q3 2014, its #526 holding.
  • UBS first reported a position in Viatris in Q2 2013 and has held it in 6 quarters since.
  • 629 funds tracked by Wall St. Rank held Viatris as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.